Vaiman Dany 4

4 · Flora Growth Corp. · Filed Jul 2, 2025

Form 4

Period: 2025-06-30

CFO

Transactions

Award
Stock Appreciation Rights ("SARs")
2025-06-30+342,888→ 342,888 total
Exercise: $0.58Exp: 2034-12-15→ Common Shares (342,888 underlying)
Disposition to Issuer
Stock Appreciation Rights ("SARs")
2025-06-30−191,773→ 0 total
Exercise: $0.92Exp: 2034-08-14→ Common Shares (191,773 underlying)
Disposition to Issuer
Stock Appreciation Rights ("SARs")
2025-06-30−372,500→ 0 total
Exercise: $1.30From: 2024-12-15Exp: 2034-12-15→ Common Shares (372,500 underlying)
Award
Stock Appreciation Rights ("SARs")
2025-06-30+372,500→ 372,500 total
Exercise: $0.58From: 2024-12-15Exp: 2034-12-15→ Common Shares (372,500 underlying)
Award
Stock Appreciation Rights ("SARs")
2025-06-30+191,773→ 191,773 total
Exercise: $0.58Exp: 2034-08-14→ Common Shares (191,773 underlying)
Disposition to Issuer
Stock Appreciation Rights ("SARs")
2025-06-30−342,888→ 0 total
Exercise: $1.21Exp: 2034-12-15→ Common Shares (342,888 underlying)

Footnotes (2)

[F1]The SARs vest in 8 equal installments, subject to stock price criteria to be met prior to each trance vesting. The SARs have a post-termination exercise period of one year.
[F2]The SARs granted to the reporting person on December 15, 2023, August 14, 2024, and December 15, 2024, were amended, with shareholder approval, to have a lower exercise price.

Documents

1 file